Symposium: The Evolution of Cellular Therapy

Moderator(s)

• 

  Sebastian Guelman, PhD

  Senior Principal Scientist
  Genentech, Inc., United States

Presentations:

• 9:30 AM – 10:00 AM ET

  Potent CRSPR-Engineered Off-The-Shelf CAR-T and TCR-T Cells Evading Host T and NK Cell Rejection
  

  Speaker: Yuanxin Xu, MD. PhD – Intellia Therapeutics
• 10:00 AM – 10:30 AM ET

  Allogeneic Cell Therapy as Transplant Medicine: Replacing or Supporting Cells in Patients That Are Dysfunctional or Absent Due to Degenerative Disease or Traumatic Injury
  

  Speaker: Brian M. Culley, BS, MS, MBA – Lineage Cell Therapeutics, Inc.
• 10:30 AM – 11:00 AM ET

  γδ T Cells – An Unconventional T Cell Platform in Fight Against Cancer
  

  Speaker: Kondala R. Atkuri, PhD (he/him/his) – Takeda Pharmaceutical Company Limited